Untranslated

More Language

86-21-64556180

cpd-service@caerulumpharma.com

Gida
Game da Mu
Kayayyaki
Magani
Albarkatu
- Zazzagewa
- Gidan hotuna
FAQs
Tuntube Mu

Gida
Kayayyaki
Kwayoyin bioactive
Wasu
BTK

Rukunin samfuran

Antineoplastic
- ACC
- Adenosin A2A
- ALK
- Androgen receptor inhibitor
- Apoptosis stimulant
- ATR
- Farashin AXL
- BCl2-BH4
- Bcr-Abl
- Farashin BRAF
- BTK
- CDK
- Chk1
- CYP17
- DNA alkylating wakili
- EED
- Farashin EGFR
- EP4
- ER
- FAK
- FGFR
- Saukewa: FLT3
- Glutaminase
- IDO
- IRA
- KIT
- LXR
- MDM2
- MEK
- MET
- Nrf2
- Saukewa: P90RSK
- P97
- PAKS
- PARP
- PI3K
- Plk-1
- SMYD2
- SRC
- TOPK
- VEGFR
Magungunan hypoglycemic
Wasu
- 5HT
- AMPK
- Arginase
- CRF-1
- CXCR2
- FLAP
- Farashin FXR
- GABA
- Gi activator
- GR
- JAK
- LABA
- mAChRs
- NF-κB
- NRTI
- PPAR
- RIP1
- Farashin S1PR
- SGC
- SYK
- α2-1
- αIIbβ3
- β2-adrenoceptor
- σ1

BTK

CAT #

Sunan samfur

Bayani

da

Tuntube Mu

No. 401, hawa na 4, Ginin 6, Titin Quwu 589, Gundumar Minhang, 200241 Shanghai, Sin
86-21-64556180
A cikin China:
sales-cpd@caerulumpharma.com
Na duniya:
cpd-service@caerulumpharma.com

Tambaya

Don tambayoyi game da samfuranmu, da fatan za a bar imel ɗin ku tare da mu kuma za mu tuntuɓi a cikin sa'o'i 24.Tambaya

Sabbin Labarai

AstraZeneca yana karɓar haɓakar tsari don magungunan oncology

AstraZeneca yana karɓar haɓaka tsari don ...

AstraZeneca ta sami haɓaka ninki biyu don fayil ɗin cutar sankara a ranar Talata, bayan hukumomin Amurka da na Turai sun karɓi ƙa'idodin ƙa'idodin magungunanta, matakin farko na samun amincewar waɗannan magunguna. ...

Manyan Abubuwa 7 A cikin Binciken Magunguna A cikin 2018

Manyan Abubuwa 7 A Cikin Binciken Magunguna Na...

Kasancewar kasancewa ƙarƙashin matsin lamba don yin gasa a cikin yanayi mai ƙalubale na tattalin arziki da fasaha, dole ne kamfanonin harhada magunguna da fasahar kere-kere su ci gaba da haɓaka cikin shirye-shiryensu na R&D don ci gaba ...

ARS-1620: Sabuwar mai hanawa don KRAS-mutant cancers

ARS-1620: Sabuwar mai hanawa don K ...

A cewar wani binciken da aka buga a cikin Cell, masu bincike sun kirkiro wani takamaiman mai hanawa don KRASG12C mai suna ARS-1602 wanda ya haifar da koma baya a cikin mice. "Wannan binciken yana ba da shaida a cikin vivo shaida cewa mutant KRAS na iya zama ...

AstraZeneca yana karɓar haɓakar tsari don magungunan oncology

AstraZeneca yana karɓar haɓaka tsari don ...

AstraZeneca ta sami haɓaka ninki biyu don fayil ɗin cutar sankara a ranar Talata, bayan hukumomin Amurka da na Turai sun karɓi ƙa'idodin ƙa'idodin magungunanta, matakin farko na samun amincewar waɗannan magunguna. ...

Manyan Abubuwa 7 A cikin Binciken Magunguna A cikin 2018

Manyan Abubuwa 7 A Cikin Binciken Magunguna Na...

Kasancewar kasancewa ƙarƙashin matsin lamba don yin gasa a cikin yanayi mai ƙalubale na tattalin arziki da fasaha, dole ne kamfanonin harhada magunguna da fasahar kere-kere su ci gaba da haɓaka cikin shirye-shiryensu na R&D don ci gaba ...

prev

next

© Haƙƙin mallaka - 2015-2022: Duk haƙƙin mallaka.

FAQs
Zazzagewa
Tuntube Mu

Lambar QR

WhatsApp Online Chat!

TOP

Previous Maximize